E-Mail Abmeldung Vielen Dank für Ihre Übermittlung Falls Sie sich für ein neues Thema angemeldet haben, erhalten in Kürze eine E-Mail, in der wir Sie bitten, Ihre Änderung zu bestätigen. Für ...
E-Mail annullamento Grazie per la vostra trasmissione In caso di registrazione per un nuovo tema, riceverete a breve un’e-mail di conferma della vostra registrazione. Riceverete un'e-mail separata pe...
E-Mail Unsubscribe Thank you for your submission If you have registered for a new topic, you will receive an email shortly asking you to confirm your change. You will receive a separate ema...
E-Mail désinscription Merci pour votre transmission! Si vous vous êtes inscrit à un nouveau thème, vous recevrez bientôt un e-mail vous demandant de confirmer votre changement. Pour chaque nouvelle ...
News 2019年 04月 23日 SERV: Exceptional financial year 2018 On 3 April 2019, the Swiss Export Risk Insurance SERV published its Annual report 2018. SERV finishes the financial year with positive company ea...
Fact Sheet 2021年 03月 30日 How to do business in the UK: A cultural guide The United Kingdom is one of the largest, most competitive markets in the world. As a country with a high level of ethnic and cultural diversity,...
Actualités 2019年 04月 23日 SERV : Exercice exceptionnel 2018 Le 3 avril 2019 la SERV, l’Assurance suisse contre les risques à l’exportation a publié son rapport de gestion 2018. Elle a bouclé l’ex...
News 2020年 07月 16日 Basel is “probably the most productive life sciences location in the world” Two thirds of the value added attributable to the pharmaceutical industry as a whole in Switzerland is generated in the Basel Area, as revealed b...
Fiches d’information 2020年 11月 11日 Faire des affaires au Royaume-Uni: un guide culturel Le Royaume-Uni est l'un des marchés les plus importants et les plus concurrentiels au monde. Caractérisé par une grande diversité ethnique et cul...
News 2020年 02月 24日 The pharma centers of Basel and India are influencing each other Basel has long been one of the world’s most important locations within the pharmaceutical industry. But pharma firms are now starting to play an ...
News 2019年 05月 23日 Santhera receiving up to 105 million Swiss francs Pharmaceutical company Santhera has entered into a license agreement with the Chiesi Group. This will license the Santhera drug Raxone. Santhera ...
News 2019年 02月 26日 Anaveon raises CHF 35 million Anaveon, an immuno-oncology biotech, has successfully concluded a Series A financing round led by Syncona, a UK Life Sciences fund, and joined by...